volume 1, issue 3, P100192 2020
DOI: 10.1016/j.xpro.2020.100192
View full text
|
Sign up to set email alerts
|
Share

Abstract: Summary Establishment of patient-derived adult stem cell-based pancreatic (tumor) organoids was first described in 2015. Since then, multiple laboratories have demonstrated the robustness of this method. We recently described the generation of a pancreatic cancer biobank containing 30 well-characterized tumor organoid models. Here, we describe the applied methods in detail. Use of tumor-selective media prevents contamination with normal cells. Generated organoids can be cryopreserved and can serve a…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
4
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals